Sharon D. Kemp

A Novel Polymorphism at Codon 333 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Can Facilitate Dual Resistance to Zidovudine and l-2′,3′-Dideoxy-3′-Thiacytidine

John W. Mellors, Brendan A. Larder, Stuart Bloor, 1998, Journal of Virology.

Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro

Paul Kellam, Brendan A. Larder, B. Larder, 1993, Nature.

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples

Brendan A. Larder, Stuart Bloor, Margriet Van Houtte, 2000, AIDS.